CAS 83799-24-0
:Fexofenadina
- 2-(4-[1-Hydroxy-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butyl]-phenyl)-2-methyl-propionic acid
- 2-(4-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]phenyl)-2-methylpropanoic acid
- 2-[4-(1-Hydroxy-4-{4-[Hydroxy(Diphenyl)Methyl]Piperidin-1-Yl}Butyl)Phenyl]-2-Methylpropanoic Acid
- 4-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethylbenzeneacetic acid
- 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylphenylacetic acid
- Benzeneacetic acid, 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-
- Carboxyterfenadine
- Fexet
- Mdl 16455
- Telfast 120
- Terfenadine acid metabolite
- Terfenadine carboxylate
- Ver más sinónimos
Fexofenadine Hydrochloride
CAS:Fórmula:C32H39NO4·HClPureza:>98.0%(T)(HPLC)Forma y color:White to Almost white powder to crystalPeso molecular:538.132-(4-{1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid
CAS:Fórmula:C32H39NO4Pureza:95%Forma y color:SolidPeso molecular:501.6564Fexofenadine
CAS:Fórmula:C32H39NO4Pureza:≥ 98.0%Forma y color:White to beige powderPeso molecular:501.66Fexofenadine
CAS:Fexofenadine, a non-sedating antihistamine, treats allergies like hay fever and urticaria.Fórmula:C32H39NO4Pureza:99.35%Forma y color:White To Off-White SolidPeso molecular:501.66Fexofenadine
CAS:Producto controladoApplications The active metabolite of Terfenadine (T114500), a H1-histamine receptor antagonist.
References Garteiz, D.A., et al.: Arzneim.-Forsch., 32, 1185 (1982), Rampe, D., et al.: Mol. Pharmacol., 44, 1240 (1993), Obradovic, T., et al.: Pharm. Res., 24, 318 (2007),Fórmula:C32H39NO4Forma y color:Off-WhitePeso molecular:501.66Fexofenadine
CAS:Fexofenadine is a selective histamine H1 receptor antagonist that has been shown to be effective in the treatment of allergic rhinitis. It is well tolerated and does not have any significant drug interactions. Fexofenadine is metabolized by cytochrome P450 (CYP) enzymes and undergoes extensive first-pass metabolism. This means that it should not interact with CYP inhibitors such as ketoconazole or cimetidine, but may increase the effects of CYP inducers such as phenobarbital or rifampin. Fexofenadine has been shown to inhibit the activity of human multidrug resistance protein 1 (MDR1) and P-glycoprotein (P-gp).
Pureza:Min. 95 Area-%Forma y color:White Off-White PowderPeso molecular:501.66 g/mol






